Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**CaniSun** is a branded line of topical cannabidiol-infused broad-spectrum sunscreen products developed by CBD Brands and subsequently associated with Jupiter Wellness. Commercial CaniSun formulations combine hemp-derived cannabidiol with the organic UV filters avobenzone, homosalate, octisalate, and octocrylene; labeled OTC sunscreen variants include SPF 30, SPF 50, and SPF 55 lotion products, with certain products also sold as continuous sprays. The UV filters provide UVA and UVB protection by absorbing ultraviolet radiation, while cannabidiol is included as a non-sunscreen ingredient. Jupiter Wellness announced a clinical evaluation of CaniSun lotion for treatment and prophylaxis of actinic keratosis, although the commercial OTC label indication is prevention of sunburn. ([accessnewswire.com](https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/jupiter-wellness-initiates-clinical-study-of-canisuntm-for-the-treatme-618204))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CaniSun.